Skip to main content
. 2019 Mar 18;17(2):eAO4435. doi: 10.31744/einstein_journal/2019AO4435

Table 2. Brazilian scale of drugs with anticholinergic activity.

Score 3 Score 2 Score 1



ATC Drug ATC Drug ATC Drug
A03BA04 Belladonna total alkaloids*, †,a, c, e, f N04BB01 Amantadineg, i, l, n N03AG01 Valproic acidd, n
N06AA09 Amitriptylineb, c, d, e, f, g, h, i, j, k, l, n M03BX01 Baclofenb, f, g, n N05BA12 Alprazolamd, f, i, k, n
A03BA01 Atropinea, c, d, f, g, h, i, k, l, n N03AF01 Carbamazepined, i, n J01CA01 Ampicillind, n
N04AA02 Biperidena, n A02BA01 Cimetidined, g, n C07AB03 Atenololf, i, n
R06AB01 Brompheniramine*, b, c, d, i, n M03BB03 Chlorzoxazone*, b L04AX01 Azathioprined, n
R06AE01 Buclizineb N05AA02 Cetirizinef, g, k, n G02CB01 Bromocriptined, l, n
A03BB01 Butylscopolamine, bromidea N07BC02 Levomepromazineb, l, m, n N06AX12 Bupropionf, i, n
R06AA08 Carbinoxamineb, c, d, i N03AF02 Methadonef, n C09AA01 Captoprild, i, n
M03BA02 Carisoprodol*, b, g N02AB02 Oxcarbazepined, i, n N05AN01 Lithium carbonateh, k, l, n
M03BX08 Cyclobenzaprineb, c, g, h N05AG02 Pethidined, i, l, n J01DC01 Cefoxitind, n
R06AX02 Cyproheptadineb, c, g, k, l, n R01BA02 Pimozided, i, l, n L04AD01 Cyclosporined, n
R06AA04 Clemastineb, c, d, i, R06AE07 Pseudoephedrine*,b, g, k, n N06AB04 Citalopramh, k, l, m, n
N06AA04 Clomipramineb, c, d, e, i, l, n N05AH04 Quetiapineb, f, j, l, n N03AE01 Clonazepamd, k, m, n
R06AB04 Chlorpheniramineb, c, d, e, f, g, i, k, n     N05BA02 Chordiazepoxide*, d, f, n
N05AA01 Chlorpromazineb,c, d, e, f, g, i, l, n     C03BA04 Chlorthalidoned, i, n
N05AH02 Clozapineb, c, d, h, i, j, l, n     R05DA04 Codeined, f, i, k, m, n
G04BD10 Darifenacina, c, d, i     M04AC01 Colchicinei, n
N06AA01 Desipramineb, c d, i     R06AX27 Desloratadineb
R06AB06 Dexbrompheniramine*, b, c     H02AB02 Dexamethasoned, n
R06AB02 Dexchlorpheniramineb, c, e, k, n     N05BA01 Diazepamd, f, i, j, k, l, m, n
R06AA02 Diphenhydramineb, c, d, f, g, i, n     C01AA05 Digoxind, i, j, k, n
R06AA02 Dimenhydrinateb, c, d, i, n     C08DB01 Diltiazemd, n
R06AA09 Doxylamine*, b, c     B01AC07 Dipyridamoled, i
N05AB02 Fluphenazineb, g, k, n     A03FA03 Domperidoneb, k, l, m, n
N05BB01 Hydroxyzineb, c, d, e, g, i, n     N04BX02 Entacaponeg, n
A03BA03 Hyoscyamine*, a, c, d, g, h, i     N06AB10 Escitalopramh, k, m
A03CB04 Homatropinea, c, f     A02BA03 Famotidined, n
N06AA02 Imipramineb, c, d, e, f, g, i, k, l, n     N03AA02 Phenobarbitalf, j
R03BB01 Ipratropiuma, j, n     N01AH01 Fentanyld, i, l, m, n
N06AA21 Maprotilineb, e, n     R06AX26 Fexofenadineb
R06AE05 Meclizineb, c, d, g, i     N06AB03 Fluoxetined, f, h, k, l, m, n
N06AA10 Nortriptylineb, c, d, f, i, j, l, n     N06AB08 Fluvoxamined, i, k, n
N05AH03 Olanzapineb, c, i, j     C03CA01 Furosemided, i, j
M03BC01 Orphenadrine*,b, c, d, e, i, j, l     J01GB03 Gentamicind, n
G04BD04 Oxybutynina, c, d, e, g, i, j, l, n     N05AD01 Haloperidolb, g, i, m, n
N06AB05 Paroxetinec, i, j     C02DB02 Hydralazined, i
R06AD02 Promethazineb, c, d, g, i, l, n     H02AB09 Hydrocortisoned, i, n
G04BD08 Solifenacina, c, n     C01DA08 Isosorbided, i, n
N05AC02 Thioridazineb, c, d, f, g, h, i, j     R06AE09 Levocetirizineb, m
R03BB04 Tiotropiuma     N04BA02 Levodopa + carbidopaf, g, k, n
M03BX02 Tizanidineb, g, n     A07DA03 Loperamided, f, i, k, m
G04BD07 Tolterodinea, c, d, f, h, i, k, n     R06AX13 Loratadineb, f, k
N04AA01 Trihexyphenidyla, c, d, e, f, i, j, l, n     N05BA06 Lorazepamd, n
N05AB06 Trifluoperazineb, c, g, i     H02AB04 Methylprednisoloned, n
R06AX07 Triprolidineb, c     A03FA01 Metoclopramideb, g, k, n
        C07AB02 Metoprololf, i, n
        N05CD08 Midazolamd, n
        N06AX11 Mirtazapineg, h, l, m, n
        N02AA01 Morphined, f, i, m, n
        C08CA05 Nifedipined, i, n
        N02AA05 Oxycodoned, f, k, m, n
        J01CA12 Piperacillin*, d, n
        N04BC05 Pramipexoleg, n
        H02AB06 Prednisoloned, l, n
        H02AB07 Prednisoned, i, n
        A02BA02 Ranitidineg, h, i, k, m, n
        N05AX08 Risperidoneb, f, g, i, k, m, n
        N04BD01 Selegilineg, n
        N06AB06 Sertralined, f, l, n
        R03DA04 Theophyllined, i, m, n
        N02AX02 Tramadold, m, n
        N02AX05 Trazodonef, g, i, m, n
        H02AB08 Triamcinoloned, n
        C03DB02 Triamterene*, d, i, n
        J01XA01 Vancomycind, n
        B01AA03 Warfarined, n
        N06AX16 Venlafaxinef, k

* Drugs marketed only in a combined, fixed dose; Fluid extract of Atropa belladona Linné. aAnticholinergic drugs described by Puustinen et al.,( 24 ) and Brown et al.;( 25 )bdrugs with known anticholinergic activity described by Nishtala et al.,( 2 ) Salahudeen et al.,( 8 ) Hilmer et al.,( 23 ) and Puustinen et al.;( 24 )cdrugs with strong anticholinergic activity described in the 2015 American Geriatrics Society Beers Criteria;( 26 )dAnticholinergic Drug Scale;( 5 )eAnticholinergic Burden Classification;( 9 )fClinician-Rated Anticholinergic Score;( 10 )gAnticholinergic Risk Scale;( 11 )hSerum Anticholinergic Activity;( 12 ) iAnticholinergic Cognitive Burden Scale;( 13 )jAnticholinergic Activity Scale;( 14 )kAnticholinergic Load Scale;( 15 )lAnticholinergic Effect on Cognition;( 16 )mMuscarinic Acetylcholinergic Receptor Antagonist Exposure;( 4 )nAnticholinergic Impregnation Scale.( 3 )